| Gene symbol | CCR5 | Synonyms | CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p21.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | C-C motif chemokine receptor 5 | ||||
| GTO ID | GTC1514 |
| Trial ID | NCT02378922 |
| Disease | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma |
| Altered gene | CCR5 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Cal-1 |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | Autologous Transplantation and Stem Cell-Based Gene Therapy With LVsh5/C46 (CAL-1), a Dual Anti-HIV Lentiviral Vector, for the Treatment of HIV-Associated Lymphoma |
| Year | 2015 |
| Country | United States |
| Company sponsor | Fred Hutchinson Cancer Center |
| Other ID(s) | 9183|NCI-2015-00149|9183|P30CA015704 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||